India records 16,906 new cases of COVID-19, active instances to 1,32,457 46 minutes ago
New strain of Omicron first noticed in India in May: WHO 3 hours ago
Restart consciousness
The Unsung Hero of Holistic Recovery
Technological disruption in India and pharmacy
Are you up for the challenge?
Holistic solutions for a healthier India
July 17
Adopt dynamic technologies
More than 125,000 industry leaders read it every day
The developing anti-diabetic market, valued at around Rs 17 billion rupees, is expected to witness the action with the release of generic versions of the US-based Merck blockbuster. In the U. S. , Januvia, reducing the cost of treatment by a third. major antidiabetic drug, which lost its patent coverage in July.
The use of antacids, which can cause abnormal heartbeat and plaque buildup in the arteries, increases the risk of developing cardiovascular disease in other people with GERD.